Gland Pharma Gets USFDA Approval For Vasopressin In 5% Dextrose RTU Injection
ReutersAug 26, 2025 6:28 AM
Aug 26 (Reuters) - Gland Pharma Ltd GLAD.NS:
GLAND PHARMA RECEIVES USFDA APPROVAL FOR VASOPRESSIN IN 5% DEXTROSE RTU INJECTION
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Nvidia Q2 Earnings Expectations: With Little Room for Error, Will China-Related Risks Be Magnified?
TradingKey - Ahead of Nvidia Q2 FY2026 earnings report, multiple Wall Street firms have raised their price targets on Nvidia, reflecting strong confidence in AI demand. While analysts continue to forecast robust ~50% year-over-year growth in revenue and EPS, the China variable remains a major riskTradingKey
43 minutes ago
Trump to Sack Cook: Why the Fed Must Maintain Its Independence?
TradingKey - On 25 August 2025, Trump announced the immediate dismissal of Cook from her position as a Federal Reserve Governor, citing "false statements in mortgage loan documents." On the surface, this appears to be an action targeting an individual official's conduct.TradingKey
2 hours ago
What to Watch in Nvidia’s Q2 FY2026 Earnings: AI Growth, Margins, and Market Impact
TradingKey - NVIDIA Corporation (NASDAQ: NVDA) will report its Q2 FY2026 earnings on Wednesday, August 27, 2025, after the U.S. market closes. The earnings call is scheduled for 5:00 p.m. Eastern Time. With Nvidia being a bellwether in AI, gaming, and data center markets, and carrying significant...TradingKey
19 hours ago
Fed at a Crossroads: Powell Faces the Spotlight at Jackson Hole in a Moment of Fed Uncertainty
TradingKey - The annual Jackson Hole Symposium is currently underway, with Federal Reserve Chair Jerome Powell’s speech on Friday, August 22, drawing global attention. Amid growing internal divisions within the Fed and external pressure from the Trump administration to reshape its leadership, willTradingKey
Fri, Aug 22
Eurozone Q2 GDP Commentary: Will the Euro's Upward Momentum Persist?
TradingKey - On 14 August 2025, Eurostat published Q2 GDP figures, revealing a drop in the Eurozone's quarter-on-quarter growth from 0.6% in the first quarter to 0.1%. Consequently, annual growth eased from 1.5% to 1.4%. The slowdown primarily stems from the diminishing boost from European...TradingKey
Mon, Aug 18
